Related Experiment Video
Updated: Aug 19, 2025

09:51
Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
Published on: May 25, 2018
34.2K
An efficient CRISPR/Cas9 platform for targeted genome editing in rose (Rosa hybrida)
Chengpeng Wang1, Yang Li1, Na Wang1
1Beijing Key Laboratory of Development and Quality Control of Ornamental Crops, Department of Ornamental Horticulture, China Agricultural University, Beijing, 100193, China.
Journal of Integrative Plant Biology
|December 2, 2022
Summary
Researchers developed an efficient CRISPR/Cas9 gene editing system for roses (Rosa hybrida). This breakthrough enables precise genetic modification, leading to ethylene-insensitive roses and advancing rose molecular breeding.
Area of Science:
- Plant Biotechnology
- Molecular Biology
- Genomics
Background:
- The clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-related nuclease 9 (Cas9) system is a powerful gene editing tool, but its application in roses (Rosa hybrida) has been limited.
- Roses possess complex genomes and lack efficient transformation methods, hindering the adoption of CRISPR/Cas9 technology.
Purpose of the Study:
- To establish an efficient CRISPR/Cas9 gene editing platform for roses.
- To optimize single-guide RNA (sgRNA) screening for high editing efficiency in rose suspension cells.
- To demonstrate the system's utility by editing the RhEIN2 gene and inducing ethylene insensitivity.
Main Methods:
- Developed a suspension cell-based platform for screening highly efficient sgRNAs for CRISPR/Cas9 in roses.
- Utilized the Arabidopsis thaliana U6-29 promoter to drive sgRNA expression, enhancing the CRISPR/Cas9 system's activity.
- Applied the optimized CRISPR/Cas9 system to target and edit the RhEIN2 gene in roses.
Main Results:
- Successfully established an efficient CRISPR/Cas9 gene editing system for roses.
- Identified highly effective sgRNAs for precise gene editing in rose suspension cells.
- Achieved successful editing of the RhEIN2 gene, resulting in ethylene insensitivity in the modified roses.
Conclusions:
- The optimized CRISPR/Cas9 system offers a robust tool for gene editing in roses.
- This technology facilitates functional genomics, molecular breeding, and synthetic biology applications in rose research.
- The development opens new avenues for genetic improvement and trait manipulation in roses.
Related Concept Videos
CRISPR/Cas9 Genome Editing
132
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
132
CRISPR
52.7K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.7K
Conservative Site-specific Recombination and Phase Variation
6.1K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
6.1K

